FDA Approves Clinical Trial of Inhaled Lung Solution for COVID

The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection – Full Text View.

Source: The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection – Full Text View – ClinicalTrials.gov



Support Independent Media for Just $2.99/Month! Get a special subscriber only podcast, access to our discord server, and direct access to the show’s hosts for comments and questions

Subscribe for $2.99/month